Cargando…
Mitophagy in Alzheimer’s disease: Molecular defects and therapeutic approaches
Mitochondrial dysfunctions are central players in Alzheimer’s disease (AD). In addition, impairments in mitophagy, the process of selective mitochondrial degradation by autophagy leading to a gradual accumulation of defective mitochondria, have also been reported to occur in AD. We provide an update...
Autores principales: | Mary, Arnaud, Eysert, Fanny, Checler, Frédéric, Chami, Mounia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812780/ https://www.ncbi.nlm.nih.gov/pubmed/35665766 http://dx.doi.org/10.1038/s41380-022-01631-6 |
Ejemplares similares
-
Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer’s Disease
por: Eysert, Fanny, et al.
Publicado: (2020) -
Alterations of the Endoplasmic Reticulum (ER) Calcium Signaling Molecular Components in Alzheimer’s Disease
por: Chami, Mounia, et al.
Publicado: (2020) -
Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer’s disease models and human brains
por: Vaillant-Beuchot, Loan, et al.
Publicado: (2020) -
Ryanodine receptors: Dual contribution to Alzheimer disease?
por: Chami, Mounia, et al.
Publicado: (2014) -
Ryanodine receptors: physiological function and deregulation in Alzheimer disease
por: Del Prete, Dolores, et al.
Publicado: (2014)